Your browser doesn't support javascript.
loading
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Bowen, Stephen R; Hippe, Daniel S; Thomas, Hannah M; Sasidharan, Balukrishna; Lampe, Paul D; Baik, Christina S; Eaton, Keith D; Lee, Sylvia; Martins, Renato G; Santana-Davila, Rafael; Chen, Delphine L; Kinahan, Paul E; Miyaoka, Robert S; Vesselle, Hubert J; Houghton, A McGarry; Rengan, Ramesh; Zeng, Jing.
Afiliación
  • Bowen SR; Radiation Oncology and.
  • Hippe DS; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Thomas HM; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Sasidharan B; Department of Radiation Oncology, Christian Medical College, Vellore, India.
  • Lampe PD; Department of Radiation Oncology, Christian Medical College, Vellore, India.
  • Baik CS; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Eaton KD; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Lee S; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Martins RG; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Santana-Davila R; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Chen DL; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Kinahan PE; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Miyaoka RS; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Vesselle HJ; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Houghton AM; Radiology, University of Washington School of Medicine, Seattle, Washington.
  • Rengan R; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Zeng J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Adv Radiat Oncol ; 7(2): 100857, 2022.
Article en En | MEDLINE | ID: mdl-35387421

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Radiat Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Radiat Oncol Año: 2022 Tipo del documento: Article